
While treatments are available for hepatitis B virus, no long-term cure has been developed. Progress so far indicates that this core inhibitor candidate is potentially ready for clinical studies.
While treatments are available for hepatitis B virus, no long-term cure has been developed. Progress so far indicates that this core inhibitor candidate is potentially ready for clinical studies.
No new safety concerns with this COVID-19 vaccine were reported.
Hebah Ibrahim Al Zamel, MSN, CIC, CPHQ, currently living in Dubai discusses becoming a member of the APIC CDS Education Committee and what infection prevention is like in Dubai.
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 11, 2022.
Infection prevention and control personnel don't elect to ever stop. Dr. Popescu tells us what's in the news this week of the mid-term elections.
Extra-intestinal pathogenic Escherichia coli (ExPEC) and Staphylococcus aureus (S. aureus) are 2 of the leading causes of severe sepsis, and Janssen Pharmaceutical Companies of Johnson & Johnson is developing vaccines to fight those diseases.
Association for Professionals in Infection Control and Epidemiology’s (APIC’s) CDS Conference is virtual this year, and the topics are environmental hygiene and sterile processing.
What can the individual do, especially those who are underserved, to protect themselves against sexually transmitted infections, including chlamydia, gonorrhea, and syphilis, and complicated with monkeypox.
While sequencing-based diagnostics have been used since the 1970s, only recently has the technology been used for infectious diseases.
CDC discusses potential proposals to redefine spread and to produce uniform guidelines across different types of facilities because public health interventions do not cause immunological debt but instead may prevent immunocompromising infections.
From safety to infection control, facial recognition in health care facilities is a new tool to keep both patients and staff safe from workplace violence.
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 4, 2022.
Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.
What is scary in infection prevention and control? Dr. Popescu tells us what's in the news this week of Halloween.
Infection prevention in pediatrics is crucial to keep babies and children healthy. Some of the main tools are hand washing and vaccinations; however, there is more to do.
What exactly does an infection preventionist (IP) do all day? One IP gives ICT’s readers an inside look.
Respiratory syncytial virus (RSV) can be deadly for newborns and young infants. The newest information from Pfizer about its RSCpreF investigational vaccine is promising for new mothers and infants through the first 90 days of life.
Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in health care facilities today.
Despite study results that the univalent BA.5 booster produced much higher increase in antibodies, why was the hybrid bivalent Ancestral/BA.5 booster with a significantly lower increase chosen to be distributed, and how does this put the population at risk?
Can antimicrobial products withstand day-to-day real-life wear and tear if the antimicrobial material is part of the product and not only a coating? A study in Switzerland tried to find out.
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending October 28.
Temporary isolation wards were used continually throughout 2021, during a surge in community transmission driven by the COVID-19 Delta variant, but were the wards effective in keeping down environmental transmission?
Using behavior modification to keep the hospitals' tiniest patients safer.
Infection preventionists and perioperative nurses should collaborate to track and share infection rate data and participate in interdisciplinary workgroups to emphasize patient safety amid burnout and staffing and supply shortages.
"Although we have numerous strategies for improving prevention and control in our facilities," Heather Saunders, MPH, RN, CIC, in her third and final of 3 series on the 3'Cs of how to be a successful IP. "All too often these strategies fall short of succeeding." Why? Lack of collaboration. Read on to see how IPs can use the 3 C's to be more successful IPs.